Titel Participants Inhoud "Bioparticle characterization and identification using interface thermal resistance measurement during bioparticle adhesion and detachment" "Ward DE CEUNINCK, Patrick WAGNER, Ronald THOELEN, Patricia LOSADA-PEREZ, Mehran KHORSHID" "The present disclosure relates to a method for characterizing and identifying a bioparticle. The method comprises introducing the sample to a substrate having a surface comprising a plurality of binding sites whereon bioparticles can be bound, determining, for at least one temperature, data representative for the interface thermal resistance of the surface of the substrate sufficiently long to include the detachment process of the bioparticles, and deriving, for the at least one temperature, a bioparticle retention time and/or detachment rate from the data representative for the interface ..." "Drug-target identification by rapid selection of drug resistance mutations" "Dirk Daelemans, Jasper Neggers" "The present invention relates to methods used in functional genomics that focus on gene function in a cell. The invention also relates to mutagenizing genes and generation of functional genetic mutants. The current invention also relates to methods for stimulus/drug-target identification. In addition, the invention relates to the generation of cell lines showing a functional phenotype, most notably stimulus/drug-resistant cell lines. The current invention further relates to methods for identification of mutations conferring this phenotype. The current invention further relates to said methods ..." "Drug-target identification by rapid selection of drug resistance mutations" "Dirk Daelemans, Jasper Neggers" "The present invention relates to methods used in functional genomics that focus on gene function in a cell. The invention also relates to mutagenizing genes and generation of functional genetic mutants. The current invention also relates to methods for stimulus/drug-target identification. In addition, the invention relates to the generation of cell lines showing a functional phenotype, most notably stimulus/drug-resistant cell lines. The current invention further relates to methods for identification of mutations conferring this phenotype. The current invention further relates to said methods ..." "Agents for increased resistance against oxidative stress conditions" "Bruno Cammue, Delphine Carron, David Cassiman, Barbara De Coninck, Janick Mathys, Pieter Spincemaille, Karin Thevissen" "The present invention relates to methods and materials able to confer an increased tolerance or resistance to oxidative stress in cells or organisms. In particular, the present invention provides peptides possessing pharmacological or biotherapeutic activity and nucleic acids encoding said peptides which can be used to improve the tolerance of a microbial or eukaryotic cell to oxidative stress, to confer oxidative stress tolerance to an organism when transfected herein, or for the treatment and the prophylaxis of a wide range of oxidative stress-related pathologies in mammals, including ..." "NEAR FULL-GENOME ASSAY OF HCV DRUG RESISTANCE" "Joke Snoeck, Sonia Van Dooren, Anne-Mieke Vandamme" "The invention relates to assays for characterization of genotypic mutations of Hepatitis C Virus (HCV) showing a resistance to anti-HCV drugs." "Method for increasing the fouling resistance of inorganic membranes by grafting with organic moieties" "Ghulam Mustafa, Vera Meynen" "Provided herein are filtration membranes for water treatment, and methods for preventing fouling of such membranes. The method described herein comprises grafting the membrane surface with an organic moiety, by reacting the surface with an organometallic reagent, a phosphonate, a phosphinate, or an organosilane." "RESISTANCE TO OXIDATIVE STRESS" "Paul Holvoet, Heinrich Huber, Maarten Hulsmans, Chantal Mathieu, Bart Van Der Schueren" "The disclosure relates to diagnosis and/or prognosis of type 2 diabetes (T2DM) in relation to obesity and prediction of response to treatment for T2DM. The determination of a patient's risk of developing T2DM and/or the prediction of a subject's response to treatment for T2DM is based on a biomarker profile comprising at least one of the genes COX4I1, COX10, PTGS1, PTGS2, and SOD2. The gene(s) may be measured in monocytes, or microvesicles derived from monocytes, or cells derived from white or brown adipose tissues." "Method for increasing the fouling resistance of inorganic membranes by grafting with organic moieties" "Ghulam Mustafa, Vera Meynen" "Provided herein are filtration membranes for water treatment, and methods for preventing fouling of such membranes. The method described herein comprises grafting the membrane surface with an organic moiety, by reacting the surface with an organometallic reagent, a phosphonate, a phosphinate, or an organosilane." "Heat-transfer resistance based analysis of bioparticles" "Ward DE CEUNINCK, Patrick WAGNER, Bart VAN GRINSVEN, Kasper EERSELS, Anitha ETHIRAJAN, Marloes PEETERS" "A bio-sensing device (100) suitable for the detection and/or characterization of target bioparticles, such as biological cells, and corresponding method is described. The bio-sensing technique is based on the impact on the heat transfer resistivity value of bioparticles binding in binding cavities of a structured substrate, such as substrates coated by molecularly imprinted polymers. By sensing temperatures and determining a heat transfer resistivity value based thereon, a characteristic of the target bioparticles can be derived." "Heat-transfer resistance based analysis of bioparticles" "Ward DE CEUNINCK, Patrick WAGNER, Bart VAN GRINSVEN, Kasper EERSELS, Anitha ETHIRAJAN, Marloes PEETERS" "A bio-sensing device suitable for the detection and/or characterization of target bioparticles and corresponding method is described. The bio-sensing technique is based on the impact on the heat transfer resistivity value of bioparticles binding in binding cavities of a structured substrate. By sensing temperatures and determining a heat transfer resistivity value based thereon, a characteristic of the target bioparticles can be derived."